ID   EMT6-LM2
AC   CVCL_RS43
SY   EMT6-Lung Metastasis passage 2
DR   Wikidata; Q54832295
RX   PubMed=29467918;
CC   Characteristics: Established from parent cell line by two passages in nude mice from spontaneous lung metastases following subcutaneous growth.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cCRGL.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1923 ! EMT6
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 5
//
RX   PubMed=29467918; DOI=10.18632/oncotarget.23795; PMCID=PMC5805504;
RA   Yingling J.M., McMillen W.T., Yan L., Huang H., Sawyer J.S., Graff J.,
RA   Clawson D.K., Britt K.S., Anderson B.D., Beight D.W., Desaiah D.,
RA   Lahn M.M., Benhadji K.A., Lallena M.J., Holmgaard R.B., Xu X.-H.,
RA   Zhang F.-M., Manro J.R., Iversen P.W., Iyer C.V., Brekken R.A.,
RA   Kalos M.D., Driscoll K.E.;
RT   "Preclinical assessment of galunisertib (LY2157299 monohydrate), a
RT   first-in-class transforming growth factor-beta receptor type I
RT   inhibitor.";
RL   Oncotarget 9:6659-6677(2018).
//